To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Cepheid
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Cepheid in an amount not to exceed $272,649 and their Multi-Year Reagent Agreement for the purchase of reagents and supplies for COVID-19 testing for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC), for the period from January 15, 2026 through January 14, 2029.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $272,649 over a three-year period and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Cepheid was selected due to its proprietary reagents and testing kits, which are specifically designed for use with the GeneXpert analyzer currently utilized in the CCRMC Laboratory. This testing platform replaced the Abbott ID system in 2020, significantly expanding the laboratory's testing capacity by enabling the processing of multiple patient samples in a single run. This contrasts with the previous single-specimen testing model, which required more time and resources.
The Cepheid GeneXpert system provides real-time PCR diagnostic results, supporting faster and more informed clinical decision-making and improving the timeliness of patient care and treatment. In addition, the Cepheid GeneXpert reagents and testing kits enable combined testing for COVID-19, RSV, and Influenza A/B from a single patient sample, increasing efficiency and diagnostic accuracy.
On November 1, 2022, the Board of Supervisors approved item C.31 to execute purchase order #26852 with Cepheid in an amount not to exceed $2,910,000 for the purchase of reagents and supplies for COVID-19 testing for the Clinical Laboratory at the CCRMC, for the period from January 15, 2023, through Janua...
Click here for full text